| 体内研究: |
LCS-1 (20 mg/kg;每隔一天腹膜内注射,持续 14 天) 抑制 MM 生长并延长携带 MM.1S 小鼠的宿主存活期。 |
| 参考文献: |
1. Gupta A, et al. Nanocarrier Composed of Magnetite Core Coated with Three Polymeric Shells Mediates LCS-1 Delivery for Synthetic Lethal Therapy of BLM-Defective Colorectal Cancer Cells. Biomacromolecules. 2018 Mar 12;19(3):803-815. 2. Somwar R, et al. Superoxide dismutase 1 (SOD1) is a target for a small molecule identified in a screen for inhibitors of the growth of lung adenocarcinoma cell lines. Proc Natl Acad Sci U S A. 2011;108(39):16375-16380. 3. Du T, et al. Proteomic analysis identifies mechanism(s) of overcoming bortezomib resistance via targeting ubiquitin receptor Rpn13. Leukemia. 2021 Feb;35(2):550-561. |
| 溶解性: |
DMSO: soluble10mg/mL (clear solutikon, warmed) |
| 保存条件: |
-80℃(运输条件:冰袋低温运输) |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
3.92 ml |
19.6 ml |
39.2 ml |
| 5 mM |
0.784 ml |
3.92 ml |
7.84 ml |
| 10 mM |
0.392 ml |
1.96 ml |
3.92 ml |
| 50 mM |
0.078 ml |
0.392 ml |
0.784 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |